NDUFS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.063400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.990200E-01
Normal-vs-Stage2
6.642400E-01
Normal-vs-Stage3
3.618800E-01
Normal-vs-Stage4
2.588200E-01
Stage1-vs-Stage2
7.114800E-01
Stage1-vs-Stage3
2.318800E-01
Stage1-vs-Stage4
6.111200E-01
Stage2-vs-Stage3
1.961230E-01
Stage2-vs-Stage4
3.020600E-01
Stage3-vs-Stage4
5.654400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.415400E-01
Normal-vs-AfricanAmerican
4.015000E-01
Normal-vs-Asian
6.464000E-01
Caucasian-vs-AfricanAmerican
4.347400E-01
Caucasian-vs-Asian
6.217200E-01
AfricanAmerican-vs-Asian
8.908400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.634400E-01
Normal-vs-Female
6.463200E-01
Male-vs-Female
3.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.041800E-01
Normal-vs-Age(41-60Yrs)
4.843000E-01
Normal-vs-Age(61-80Yrs)
8.194600E-01
Normal-vs-Age(81-100Yrs)
6.617800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.004400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.143000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.355200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.894300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.541200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.636000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.494000E-01
Normal-vs-Daily Drinker
8.302200E-01
Normal-vs-Weekly Drinker
7.372800E-01
Normal-vs-Occasional Drinker
3.655400E-01
Normal-vs-Social Drinker
6.655600E-01
Non Drinker-vs-Daily Drinker
7.776400E-01
Non Drinker-vs-Weekly Drinker
3.735800E-01
Non Drinker-vs-Occasional Drinker
5.324400E-02
Non Drinker-vs-Social Drinker
3.632800E-01
Daily Drinker-vs-Weekly Drinker
3.515800E-01
Daily Drinker-vs-Occasional Drinker
2.860000E-02
Daily Drinker-vs-Social Drinker
2.333600E-01
Weekly Drinker-vs-Occasional Drinker
5.775000E-01
Weekly Drinker-vs-Social Drinker
8.931400E-01
Occasional Drinker-vs-Social Drinker
3.601200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.719240E-01
Normal-vs-Grade 2
7.178100E-02
Normal-vs-Grade 3
3.378300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.410000E-02
Grade 1-vs-Grade 3
1.027630E-02
Grade 1-vs-Grade 4
1.719240E-01
Grade 2-vs-Grade 3
5.639400E-01
Grade 2-vs-Grade 4
7.178100E-02
Grade 3-vs-Grade 4
3.378300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.576600E-01
Normal-vs-NonDiabetic
7.694200E-01
Diabetic-vs-NonDiabetic
4.574200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.276400E-01
Normal-vs-NoPancreatitis
7.784600E-01
Pancreatitis-vs-NoPancreatitis
6.812200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.179400E-01
Normal-vs-N1
6.808600E-01
N0-vs-N1
8.466400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.001800E-01
Normal-vs-TP53-NonMutant
7.585400E-01
TP53-Mutant-vs-TP53-NonMutant
9.761900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
